Beijing, China

Bisheng Jiang

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):

Title: The Innovative Contributions of Bisheng Jiang

Introduction

Bisheng Jiang is a notable inventor based in Beijing, China. He has made significant contributions to the field of molecular testing through his innovative patent. His work focuses on enhancing the efficiency of polymerase chain reaction (PCR) methods, which are crucial in various biological and medical applications.

Latest Patents

Bisheng Jiang holds a patent for a technology known as Primer Middle Sequence Interference PCR. This method utilizes a segment of a non-complemented or same-sequence base from the middle sequence of primers to perform antisense interference. The technique aims to competitively disrupt the polymerization among primers, selectively inhibiting the amplification of primer dimers (PD). This innovation represents a significant advancement in PCR technology, allowing for more precise and effective testing.

Career Highlights

Bisheng Jiang is associated with Beijing Tag-array Molecular Test Co., Ltd., where he applies his expertise in molecular testing. His work at the company has positioned him as a key player in the development of advanced testing methodologies. With a focus on improving PCR techniques, he has contributed to the enhancement of diagnostic capabilities in various fields.

Collaborations

Bisheng Jiang collaborates with talented individuals such as Hong Jiang and Suwen Yue. Their combined efforts in research and development have fostered an environment of innovation and progress within their field.

Conclusion

Bisheng Jiang's contributions to PCR technology exemplify the impact of innovative thinking in the scientific community. His patent and work at Beijing Tag-array Molecular Test Co., Ltd. highlight the importance of advancements in molecular testing. Through his efforts, he continues to pave the way for future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…